1-7 of 7
Richard E. Davis, M.D.
Close
Sort by
Journal Articles

Proteomic, Gene Expression, and Micro-RNA Analysis Of Bone Marrow Mesenchymal Stromal Cells In Acute Myeloid Leukemia Identifies Pro-Inflammatory, Pro-Survival Signatures In Vitro and In Vivo

Michael Andreeff, MD, PhD, Rui-yu Wang, MD, PhD, Richard E. Davis, M.D., Rodrigo Jacamo, PhD, Peter P. Ruvolo, PhD, Teresa McQueen, BS, Xielin Huang, PhD, Venkata L Battula, Ph.D., Ye Chen, PhD, Shonali Majumdar, Juliana M Benito, PhD, Zhihong Zeng, MD, Christopher B. Benton, MD, Bing Z Carter, PhD, Hong Mu, MD, PhD, Wencai Ma, Ph.D., Vivian R Ruvolo, MA, Lauren Hodgson, Sergej Konoplev, MD, PhD, Rongqing Pan, MS, Anitha Somanchi, Dirk Strunck, Qiguo Zhang, Steven M. Kornblau, MD, Hagop M Kantarjian, MD, Guido Marcucci, MD, Ramiro Garzon, MD, Johannes Zuber, Scott W. Lowe, PhD, Carlo M. Croce, MD, Marina Konopleva, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3685.
https://doi.org/10.1182/blood.V122.21.3685.3685
Published: 2013
Journal Articles

Bone Marrow Microenvironment Induces Stem Cell-Like Phenotype In Acute Myeloid Leukemia

Venkata L Battula, Ph.D., Juliana M Benito, PhD, Anitha Somanchi, Seshagiri Duvvuri, Lauren Hodgson, Ye Chen, PhD, Wencai Ma, Ph.D., Richard E. Davis, M.D., Ian K. McNiece, PhD, Elizabeth J Shpall, MD, Marina Konopleva, MD, PhD, Michael Andreeff, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2457.
https://doi.org/10.1182/blood.V122.21.2457.2457
Published: 2013
Journal Articles

The Novel Human Double Minute (HDM)-2 Inhibitor DS-5272 Is Active Both Alone, and In Combination With Other Novel Agents, Against Multiple Myeloma

Dongmin Gu, M.D., Ph.D., Hua Wang, Ph.D., Zhiqiang Wang, Ph.D., Richard E. Davis, M.D., Shengli Cai, M.D., Ph.D., Takahiko Seki, Ph.D., Archie Tse, M.D., Ph.D., Robert Z. Orlowski, M.D., Ph.D
Journal: Blood
Blood (2013) 122 (21): 1927.
https://doi.org/10.1182/blood.V122.21.1927.1927
Published: 2013
Journal Articles

Expression Of Truncated Protein Tyrosine Phosphatase, Receptor Type, O (PTPROt) Influences Multiple Myeloma Sensitivity To Bortezomib Through Akt Signaling, and Is a Favorable Clinical Prognostic Factor

Hua Wang, Ph.D., Veerabhadran Baladandayuthapani, Ph.D., Zhiqiang Wang, Ph.D., Jiexin Zhang, Heather Yan Lin, Ph.D., Richard E. Davis, M.D., Lin Yang, Robert Z. Orlowski, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 2520.
https://doi.org/10.1182/blood.V122.21.2520.2520
Published: 2013
Journal Articles

CX-5461, a Novel RNA Polymerase I Inhibitor, Is Active Against Wild-Type and Mutant p53 Myeloma Models

Hans C. Lee, MD, Hua Wang, Ph.D., Bing-Zong Li, M.D., Ph.D., Zhiqiang Wang, Ph.D., Richard Julian Jones, Ph.D., Dongmin Gu, M.D., Ph.D., Sean O'Brien, Ph.D., Richard E. Davis, M.D., Robert Z. Orlowski, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 4438.
https://doi.org/10.1182/blood.V122.21.4438.4438
Published: 2013
Journal Articles

Intravenous Immunoglobulin G (IVIg) Suppresses HSP70-1 and Has Potential Therapeutic Effects Against Multiple Myeloma and Lymphoma

Richard Julian Jones, Ph.D., Richard E. Davis, M.D., Robert Z. Orlowski, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 3845.
https://doi.org/10.1182/blood.V122.21.3845.3845
Published: 2013
Journal Articles

Pre-BCR Signaling Activity Predicts Sensitivity To Syk Kinase Inhibition In B Cell Acute Lymphoblastic Leukemia (B-ALL)

Stefan Koehrer, MD, Richard E. Davis, M.D., Greg Coffey, PhD, Ekaterina Kim, MS, Nathalie Y. Rosin, PhD, Elisa ten Hacken, Susan O'Brien, MD, William G. Wierda, MD, PhD, Zeev Estrov, MD, Deborah A. Thomas, MD, Hagop M. Kantarjian, MD, Zhiqiang Wang, Ph.D., Hassan Jumaa, PhD, Jan A. Burger, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 614.
https://doi.org/10.1182/blood.V122.21.614.614
Published: 2013